SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 12th, 2017 • Adial Pharmaceuticals, L.L.C. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 1, 2017, by and between ADIAL PHARMACEUTICALS, LLC, a Virginia limited liability company, with headquarters located at 204 E. High Street, Charlottesville, VA 22902 (the “Company”), and FIRSTFIRE GLOBAL OPPORTUNITIES FUND, LLC, a Delaware limited liability company, with its address at 1040 First Avenue, Suite 190, New York, NY 10022 (the “Buyer”).
EXECUTIVE EMPLOYMENT AGREEMENT William B. Stilley, IIIEmployment Agreement • May 12th, 2017 • Adial Pharmaceuticals, L.L.C. • Pharmaceutical preparations • Virginia
This Executive Employment Agreement (this “Agreement”) is effective as of December 6, 2010 (the “Effective Date”), between ADial Pharmaceuticals, LLC, a Virginia limited liability company (the “Company”), and William B. Stilley, III (“Executive”).
AMENDMENT #2 TO LICENSE AGREEMENTLicense Agreement • May 12th, 2017 • Adial Pharmaceuticals, L.L.C. • Pharmaceutical preparations
This Amendment #1, dated as of May 18, 2016 (this “Agreement”), to the Original License Agreement (as defined below) is by and between the University of Virginia Patent Foundation d/b/a the University of Virginia Licensing and Ventures Group, a Virginia not-for-profit corporation of the Commonwealth of Virginia, having its principal offices at 250 West Main Street, Charlottesville, VA 29902 (“UVA LVG”), and ADial Pharmaceuticals, LLC, a Virginia limited liability company (“Adial” and together with “UVA LVG”, the “Parties”).
LICENSE AGREEMENT Between The University of Virginia Patent Foundation And ADial Pharmaceuticals, L.L.C. Effective January 21, 2011License Agreement • May 12th, 2017 • Adial Pharmaceuticals, L.L.C. • Pharmaceutical preparations • Virginia
This Agreement is entered into and made effective as of January 21, 2011 (the “Effective Date”) by and between the University of Virginia Patent Foundation (“Foundation”), a not-for-profit corporation of the Commonwealth of Virginia having its principal offices at 250 West Main Street, Charlottesville, VA, 29902; and ADial Pharmaceuticals, L.L.C. (“Adial”), a Virginia limited liability company having its principal offices at 1001 Research Park Drive, Suite 100, Charlottesville, VA 22911.
TERMINATION AGREEMENTTermination Agreement • May 12th, 2017 • Adial Pharmaceuticals, L.L.C. • Pharmaceutical preparations
This Termination Agreement (this “Agreement”) is made effective as of the last date of signature, below (the “Effective Date”), between
